SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
BELITE BIO, INC
@BLTE_InsiderForm 4 Filing: Scholl Hendrik Peter Sells $1.4M of $BLTE
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
BELITE BIO, INC
Ticker: $BLTE
Transaction Value
$1.4M
Price/Share: $140.57
transaction date
2026-06-16
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Scholl Hendrik Peter, holds the title of Chief Medical Officer at BELITE BIO, INC.
On 2026-06-16, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $140.57 per share, resulting in a total market-relevant value of $1.4M.
Executive Summary Summary
Scholl Hendrik Peter (Chief Medical Officer) sold $1.4M of $BLTE
Post-Transaction Position: 29,022 shares
SEC Accession No: 0001193125-26-273321 (CIK: 2113223)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.